Substances from stem cells for the treatment of (neuro-) degenerative diseases
The new active agents can be used to produce
pharmaceutical substances to be used for the treatment of neurodegenerative diseases. The substances are enriched with dying stem cells. The agents are suited to disable acute or delayed dysfunctions. They prevent the dying of neuronal cells after acute injuries or during the progress of neurodegenerative disorders.
Further Information: PDF
TransMIT Gesellschaft für Technologietransfer mbH
Phone: +49 (0)641/943 64-12
Contact
Dr. Peter Stumpf
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Pinpointing hydrogen isotopes in titanium hydride nanofilms
Although it is the smallest and lightest atom, hydrogen can have a big impact by infiltrating other materials and affecting their properties, such as superconductivity and metal-insulator-transitions. Now, researchers from…
A new way of entangling light and sound
For a wide variety of emerging quantum technologies, such as secure quantum communications and quantum computing, quantum entanglement is a prerequisite. Scientists at the Max-Planck-Institute for the Science of Light…
Telescope for NASA’s Roman Mission complete, delivered to Goddard
NASA’s Nancy Grace Roman Space Telescope is one giant step closer to unlocking the mysteries of the universe. The mission has now received its final major delivery: the Optical Telescope…